Pfizer/BioNTech COVID-19 vaccine is effective in more than 90% of cases

In a statement on Monday, Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) said that their jointly developed COVID-19 vaccine is effective in more than 90% of the patients. The two drug manufacturers are the first ones to publish successful trial data, taking the world a step closer to winning the battle against the Coronavirus pandemic that has so far infected more than 50 million people worldwide and caused over 1.2 million deaths. Pfizer is still down 7% in the stock market on a year to date basis. But the shares of the company have recovered close to 25%